Astrocytes and their processes play a role in guiding the migration and axonal growth of neurons during embryonic development 1, 2) or in establishing the blood-brain barrier. [3] [4] [5] Furthermore, astrocytes become reactive in response to brain tissue damage caused by hypoxia, ischemia or seizures.
Furthermore, astrocytes become reactive in response to brain tissue damage caused by hypoxia, ischemia or seizures. 6, 7) Reactive astrocytes are characterized by stellate morphology and an increased expression of glial fibrillary acidic protein. Therefore, the study of mechanisms regulating astrocyte morphology is very important for understanding brain development and brain response to injury or disease.
Cultured astrocytes from the cerebral cortex of neonatal rats display flattened, polygonal morphology in the absence of stimuli, and change into process-bearing stellate cells in response to specific stimuli, e.g., cyclic AMP analogs, [8] [9] [10] phorbol ester [11] [12] [13] or Alzheimer's disease amyloid b protein. [14] [15] [16] [17] This morphological change is termed stellation and has been widely studied for understanding the regulatory mechanisms of astrocyte morphology.
L-Glutamate functions as a major excitatory neurotransmitter in the central nervous system. Astrocytes possess an abundance of molecules that could be the target of L-glutamate, e.g., glutamate receptors or glutamate transporters. 18, 19) However, the functional roles of L-glutamate in astrocytes are not fully understood. We have recently found that L-glutamate suppresses the astrocyte stellation induced by amyloid b protein, cyclic AMP analog or phorbol ester in culture, suggesting that L-glutamate is a regulator of astrocyte morphology. 17) The suppressive effect of L-glutamate on astrocyte stellation was not mimicked by glutamate receptor agonists, and not blocked by glutamate receptor antagonists. In contrast, the effect of L-glutamate was mimicked by D-and L-aspartate and transportable glutamate uptake inhibitors. We hypothesized that L-glutamate suppresses astrocyte stellation through a mechanism related to the glutamate transporter. To support this idea, we investigated the Na ϩ and K ϩ dependence of this effect of L-glutamate in the present study. The glutamate transporter is driven by Na ϩ influx and K ϩ efflux, 20) and the plasma membrane Na ϩ -K ϩ pump serves to maintain the gradient of extracellular and intracellular Na ϩ or K ϩ concentrations. If the effect of L-glutamate on astrocyte morphology requires the activity of glutamate transporters, it should be attenuated by lowering Na ϩ and K ϩ gradients or by inhibiting the Na
MATERIALS AND METHODS
Primary cultures of astrocytes were prepared from the cerebral cortices of 2-d-old neonates of Wistar rats, as described previously. 21) Briefly, dissociated cortical cells were suspended in modified Eagle's medium containing 30 mM glucose, 2 mM glutamine, 1 mM pyruvate and 10% fetal bovine serum, and plated on uncoated 25 cm 2 flasks at a density of 600000 cells/cm 2 . The monolayer of type I astrocytes was obtained 12-14 d after the plating. Non-astrocytes such as microglia were detached from the flasks by shaking, then removed by changing the medium. Astrocytes were dissociated by trypsinization, and then reseeded on uncoated 48-well plates at a density of 20000 cells/cm 2 . After the cells became confluent (approximately 7-8 d after), the culture medium was switched to serum-free medium, and experiments were initiated 24 h later.
To study the effect of changing Na ϩ and K ϩ concentrations or the Na ϩ -K ϩ pump inhibitor ouabain, we used a basal salt solution (BSS) in which minor constituents, including amino acids and vitamins, were omitted from serum-free modified Eagle's medium. The composition of BSS was as follows (in mM): 102 NaCl, 4.7 KCl, 0.8 NaH 2 PO 4 , 0.7 MgSO 4 , 1.6 CaCl 2 , 23 NaHCO 3 , 30 glucose, 2.2 L-glutamine, 1.1 sodium pyruvate and 0.015 phenol red (pH 7.4 under 5% CO 2 /95% air). Low-Na ϩ /high-K ϩ medium was prepared by replacing NaCl with KCl in BSS. In experiments in which the effect of changing extracellular Na ϩ or K ϩ concentration was examined, the culture medium was switched to normal BSS or low-Na ϩ /high-K ϩ BSS at a volume of 300 ml per well, and the cultures were equilibrated for 30 min prior to the addition of test drugs. In experiments in which the effect of ouabain was investigated, the culture medium was switched to 300 ml of BSS containing ouabain, and the cultures were equilibrated for 30 min prior to the addition of test drugs.
Astrocyte stellation was induced by the addition of the membrane-permeable cyclic AMP analog dibutyryl cyclic AMP (dBcAMP). Changes in cell morphology were assessed by microscopic examination. To confirm the expression of glial fibrillary acidic protein, the cells were fixed with 4% paraformaldehyde, incubated with monoclonal antibodies to glial fibrillary acid protein (Boehringer Mannheim Biochemica, Germany) and stained with a Vectastain ABC kit (Vector; Burlingame, CA, U.S.A.), as described in our previous paper. 16) Ten fields of 1 mm 2 , the total of which corresponds to 10% of the whole well area (1 cm 2 ), were chosen at random from each well. The numbers of polygonal and stellate cells in those fields were counted under a microscope, and the percentage of stellate cells was calculated. The counter was blinded to drug treatment. Each assay was done in duplicate, and the same experiments were repeated with separate cultures obtained from different litters.
RESULTS
In the absence of stimulation, cultured astrocytes exhibited flattened, polygonal morphology, typical of type I astrocytes (Fig. 1A) . When the cells were treated with 2 mM dBcAMP for 2 h, they changed into process-bearing stellate cells (Fig.   1B) . The dBcAMP-induced stellation was suppressed by the presence of 100 mM L-glutamate (Fig. 1C) . Decreasing the extracellular Na ϩ concentration from 127 mM to 93 mM and increasing the extracellular K ϩ concentration from 4.7 mM to 38.7 mM had no effect on dBcAMP-induced stellation, but significantly attenuated the suppressive effect of L-glutamate on stellation (Fig. 2A) . Since a further decrease in extracellular Na ϩ concentration (Ͻ59 mM) and an increase in extracellular K ϩ concentration (Ͼ72.7 mM) significantly suppressed dBcAMP-induced stellation, the effect of L-glutamate on astrocyte stellation was not tested in this condition. Ouabain at concentrations of 50 and 500 mM affected neither astrocyte morphology in the absence of stimulation (data not shown, nϭ5) nor the dBcAMP-induced stellation (Fig. 2B) , but significantly attenuated the suppressive effect of L-glutamate on stellation (Figs. 1D, 2B) .
The suppressive effect of L-glutamate on dBcAMP-induced stellation was mimicked by transportable glutamate uptake inhibitors, DL-threo-b -hyroxyaspartate (THA) and Ltrans-pyrrolidine-2,4-dicarboxylate (PDC), consistent with our previous observation.
17 ) The suppressive effect of THA on dBcAMP-induced stellation was significantly attenuated in low-Na ϩ /high-K ϩ BSS (Fig. 3A) , and by treatment with ouabain (Fig. 3B) . The suppressive effect of PDC on dBcAMP-induced stellation was also attenuated in low-Na ϩ / high-K ϩ BSS (data not shown, nϭ5) and by ouabain (Fig.  3C) .
To examine whether the effects of low-Na ϩ /high-K ϩ BSS and ouabain are specific for L-glutamate-induced events, we employed thrombin, which has been reported to suppress astrocyte stellation. 22, 23) Thrombin (0.001-1 mU/ml) suppressed dBcAMP-induced stellation in a concentration-dependent manner, but the effect of thrombin was not at all affected in low-Na ϩ /high-K ϩ BSS (Fig. 4A) nor by ouabain The cells were treated with none (A), 2 mM dBcAMP (B), 2 mM dBcAMPϩ100 mM L-glutamate (C) or 2 mM dBcAMPϩ100 mM L-glutamateϩ500 mM ouabain (D) for 2 h. The cells were fixed with paraformaldehyde and stained with monoclonal antibodies to glial fibrillary acidic protein. (Fig. 4B) .
DISCUSSION
The main finding in the present study was that the L-glutamate-induced suppression of astrocyte stellation was attenuated in low-Na ϩ /high-K ϩ BSS and by treatment with ouabain. The thrombin-induced suppression of astrocyte stellation was not at all affected by low-Na ϩ /high-K ϩ BSS nor ouabain, indicating that the effects of these treatments are specific for Lglutamate-induced events. The gradient of intracellular and extracellular Na ϩ or K ϩ concentrations is supposed to be reduced in low-Na ϩ /high-K ϩ BSS. The plasma membrane Na ϩ -K ϩ pump operates as an antiporter, pumping Na ϩ out of and K ϩ into a cell against their electrochemical gradients. Inhibition of the Na ϩ -K ϩ pump by ouabain is presumed to result in a reduction in the gradient of extracellular and intracellular Na ϩ or K ϩ concentrations. Therefore, the result suggests that electrochemical gradients of Na ϩ and K ϩ are required for the L-glutamate-induced suppression of astrocyte stellation.
We have previously checked the effects of low-Na ϩ /high-K ϩ BSS and ouabain on glutamate uptake in cultured rat cortical astrocytes.
24) The rate of uptake of 150 mM L-glutamate into astrocytes was reduced to 70% in low-Na
, and to 76 and 37% by treatment with 50 and 500 mM ouabain, respectively. In the present study, the 100 mM L-glutamate-induced suppression of astrocyte stellation was reduced to 64% in low-Na
, and to 75 and 30% by treatment with 50 and 500 mM ouabain, respectively. The effects of lowNa ϩ /high-K ϩ BSS and ouabain in attenuating the L-glutamate-induced suppression of astrocyte stellation correlated well with those in inhibiting glutamate uptake. These results strongly support the idea that L-glutamate suppresses astrocyte stellation through a mechanism related to the glutamate transporter.
Transportable glutamate uptake inhibitors, THA and PDC, inhibit glutamate uptake by competing with L-glutamate at the site of glutamate transporters. It is also known that these inhibitors themselves are transported by glutamate transporters and thereby produce ion fluxes and intracellular pH changes in a manner similar to L-glutamate. [25] [26] [27] THA and PDC suppressed astrocyte stellation as well as L-glutamate, and the effects of THA and PDC were attenuated in low-Na ϩ /high-K ϩ BSS and by ouabain. These results suggest that the activity of glutamate transporters rather than L-glutamate itself is important for the suppression of astrocyte stellation.
In conclusion, our findings demonstrate that the glutamate transporter in astrocytes not only serves to clear extracellular L-glutamate but also participates in the regulation of morphology. Further investigations of molecular mechanisms may reveal unknown function(s) of the glutamate transporter in addition to its role in the uptake of L-glutamate. Vol. 24, No. 1 ; ᭹), and the cultures were equilibrated for 30 min prior to assay. The cells were then exposed to 2 mM dBcAMP in the absence (0) or presence of 0.001-1 mU/ml thrombin for 2 h. (B) The cells were pretreated with ouabain (no treatment, ᭺; 50 mM, ᭹; 500 mM, ᭡) for 30 min, and then exposed to 2 mM dBcAMP in the absence (0) or presence of 0.001-1 mU/ml thrombin for 2 h. The numbers of polygonal cells and stellate cells were counted under a microscope, and the percentage of stellate cells was calculated. Data are the meansϮS.E.M. of five separate observations.
